1 January 2024
A 2024 systematic review found five of six studies reported hormone-treatment discontinuation below 10%, while one repor
A 2024 systematic review found five of six studies reported hormone-treatment discontinuation below 10%, while one reported 30.8% discontinuation or loss to follow-up (Gupta et al., 2024).